We came across a bullish thesis on Genmab A/S (GMAB) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on GMAB.
Keep Reading →
March 19 - News, Stock Analysis
Currently, big tech and high-growth stocks dominate the stock market, making up a much larger share of the broader market than they have historically.
Keep Reading →
March 7 - Hedge Funds, News
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President ...
Keep Reading →
February 24 - Hedge Funds, News
Companies experiencing above-average earnings growth, which is often fueled by innovations and market expansions, are known as growth stocks.
Keep Reading →
February 24 - Hedge Funds, News
Operator: Hello, and welcome to the Genmab Full Year 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Keep Reading →
February 17 - News, Transcripts
Leerink does not expect Johnson & Johnson (JNJ) to exercise its option to develop GMAB's GEN3014, a treatment candidate for relapsed/refractory multiple myeloma patients.
Keep Reading →
February 13 - Market Movers, News
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Keep Reading →
February 7 - Hedge Funds, Industries, News
On January 15, Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company shared his outlook for 2025.
Keep Reading →
January 22 - Hedge Funds, News
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Keep Reading →
November 30 - Hedge Funds, News
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
Keep Reading →
November 26 - Hedge Funds, News
Biotechnology stocks are among the most volatile in the market due to their high risk.
Keep Reading →
November 21 - Hedge Funds, News
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Keep Reading →
November 14 - Hedge Funds, News
Operator: Hello, and welcome to Genmab's Financial Results Conference Call for the First Nine Months of 2024. As a reminder, this conference call is being recorded.
Keep Reading →
November 11 - News, Transcripts
After the September inflation report, the market did feel a slight bit of panic but it seems to be fading away.
Keep Reading →
October 13 - Hedge Funds, News
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
Keep Reading →
October 6 - Hedge Funds, News
The Fed recently cut the funds rate by 50 basis points which has been considered a bold move by some analysts while others and most of the market have welcomed it with open arms...
Keep Reading →
September 29 - Hedge Funds, News
Several traders tend to profit from stocks through appreciation. However, some do the opposite-- their idea is to profit from stocks when their value declines.
Keep Reading →
August 27 - Hedge Funds, News
Operator: Hello, and welcome to the Genmab First Half 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Keep Reading →
August 13 - News, Transcripts
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
Keep Reading →
May 3 - News, Transcripts
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35.
Keep Reading →
February 15 - News, Transcripts
In this article, we discuss the 12 high growth international stocks to buy.
Keep Reading →
December 27 - Hedge Funds, News
In this article, we will take a look at the 5 high growth healthcare stocks to buy.
Keep Reading →
December 26 - Hedge Funds, News
Operator: Hello, and welcome to Genmab's Third Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Keep Reading →
November 8 - News, Transcripts
Operator: Hello, and welcome to Genmab's Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Keep Reading →
August 5 - News, Transcripts
Operator: Hello, and welcome to the Genmab's First Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Keep Reading →
May 14 - News, Transcripts
Growth stocks refer to listed companies that are growing their profits, revenue, or cash flow at a rate that exceeds their competitors and beats the overall market.
Keep Reading →
March 27 - Market Movers, News
SolarEdge Technologies, Inc. (NASDAQ:SEDG) was incorporated in 2006 and is headquartered in Herzliya, Israel.
Keep Reading →
February 27 - Hedge Funds, News
Operator: Hello, and welcome to the Genmab Full-year 2022 Conference Call. As a reminder, this conference call is being recorded.
Keep Reading →
February 23 - News, Transcripts
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
Keep Reading →
February 23 - Lists, News
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Keep Reading →
January 20 - Hedge Fund Investor Letters, News
The Nordic countries refer to the nation states of Norway, Sweden, Finland, Denmark, and Iceland which are located in Northern Europe.
Keep Reading →
January 2 - Lists, News
In this article, we discuss the 10 biotech stocks with the biggest upside.
Keep Reading →
December 13 - Hedge Funds, News
In this article, we discuss the 10 best immunology stocks to invest in.
Keep Reading →
December 13 - Hedge Funds, News
Alongside the United States, Europe has some of the most advanced industries and economies in the world.
Keep Reading →
November 23 - Lists, News
In this article, we discuss 5 of the most valuable Danish companies in the world.
Keep Reading →
October 11 - Hedge Funds, Lists, News
In this article, we discuss the 10 stocks that analysts are downgrading.
Keep Reading →
September 17 - Hedge Funds, News
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
Keep Reading →
September 3 - Hedge Fund Investor Letters, News
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded...
Keep Reading →
May 7 - Hedge Fund Investor Letters, News
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Keep Reading →
February 19 - Hedge Fund Investor Letters, News
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Keep Reading →
December 16 - Hedge Funds, News
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Keep Reading →
June 26 - Hedge Funds, News
We hate to say this but, we told you so.
Keep Reading →
March 18 - Hedge Funds, News
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Keep Reading →
December 14 - Hedge Funds, News